TISSUE CORE
组织核心
基本信息
- 批准号:7944905
- 负责人:
- 金额:$ 17.02万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-04-07 至 2012-03-31
- 项目状态:已结题
- 来源:
- 关键词:AccelerationAlcoholsAnatomyAnimal ModelAtlasesBiopsy SpecimenCancer Center Support GrantCategoriesClinicalClinical trial protocol documentCollaborationsCommunications PersonnelConsentContractsCore FacilityDiagnosticEpidemiologic StudiesEquipmentEquipment and supply inventoriesExcisionFloorFormalinFreezingFundingGlioblastomaGrantHarvestHealth Services ResearchHospitalsHourHumanHuman ResourcesImage AnalysisIndividualInstitutesInvestigationLaboratoriesLasersLiquid substanceMalignant NeoplasmsMedicineMicroscopyNitrogenOperating RoomsOperative Surgical ProceduresPathologistPathologyPatient CarePreparationProcessProductivityProtocols documentationRNAResearchResearch Ethics CommitteesResearch PersonnelResearch SupportResource SharingScheduleScienceScientistServicesSiteSolutionsSourceSpecimenStaining methodStainsSupport GroupsSurgical PathologyTissue BankingTissue BanksTissue MicroarrayTissue ProcurementsTissue SampleTissuesTrainingTumor BankUniversity HospitalsWorkbasecancer Biomedical Informatics Gridcancer genomeexperiencehuman diseasehuman tissuememberprogramsprospectivequality assurancerepositorysuccesstissue processingtooltumor
项目摘要
The Human Tissue and Pathology Core (Shared Resource Category 4.06) of the Winship Cancer Institute (WCI) will be critical to the overall clinical and scientific success by enhancing tissue-based investigation through its procurement and distribution of human cancer specimens and its comprehensive histopathologic services. The Core is highly integrated within the WCI, serving individual and team science projects in all of the major programs and interfacing directly with the other Cores. The tissue banking component of the Core consists of an IRB-approved Human Tissue Procurement Service (HTPS), located within the Emory University Hospital and the WCI, with affiliated banking sites at Grady Memorial and Crawford Long Hospitals. Tissue procurement personnel are highly experienced in anatomic pathology and tumor banking
protocols, with quality assurance of specimens provided by members of the Department of Pathology. Tumor and normal control tissues, along with other biospecimens associated with specialized protocols, are procured as frozen, fresh, fixed, embedded or other specialized preparation, and inventoried in caTissue Core, a caBIG tool for biospecimen repositories. Tissues are distributed to WCI investigators with IRBapproved protocols to further the clinical, translational, basic and epidemiologic research. Pathology services of the Core are provided by the Research Pathology Laboratory, a full service lab located on the 5th floor of the WCI building with experienced personnel and equipment for tissue processing, histological and immunohistochemical staining and analysis, laser capture microscopy, tissue microarrays and high
throughput, automated image analysis for immunofluorescent and bright field microscopy. This lab is capable of processing high volumes of tissue samples derived from human disease and animal models and works in close collaboration with the other Cores and scientific programs of the WCI as demonstrated by research productivity and support of group science grants. The success of this Core is also highlighted by its contract with the NCI for collecting and processing glioblastoma specimens for The Cancer Genome Atlas Project. Together, the HTPS and the Research Pathology Lab provide centralized, efficent and high quality services to WCI investigators for acceleration of scientific discovery.
Winship癌症研究所(WCI)的人体组织和病理学核心(共享资源4.06)通过通过其人类癌症标本及其全面的组织病理学服务来增强基于组织的研究,对整体临床和科学成功至关重要。核心高度集成在WCI中,为所有主要计划中的个人和团队科学项目提供服务,并直接与其他核心接触。核心的组织库组成部分由位于埃默里大学医院和WCI内的IRB批准的人体组织采购服务(HTPS)组成,格雷迪纪念馆和克劳福德·朗医院的隶属银行现场。组织采购人员在解剖病理和肿瘤库中经验丰富
协议,以及病理部成员提供的标本的质量保证。肿瘤和正常对照组织以及与专门方案相关的其他生物测量,以冷冻,新鲜,固定,嵌入式或其他专业制剂的形式获取,并在Catissue Core中库存,这是一种用于生物测量库的Cabig工具。将组织分配给WCI研究人员,该研究人员具有IRBARDED方案,以进一步进行临床,转化,基本和流行病学研究。核心的病理服务由研究病理实验室提供,这是一个完整的服务实验室,位于WCI建筑物的5楼,带有经验丰富的人员和设备,用于组织处理,组织学和免疫组织化学染色和分析,激光捕获显微镜,组织微观阵列以及高度
用于免疫荧光和明亮场显微镜的吞吐量,自动图像分析。该实验室能够处理源自人类疾病和动物模型的大量组织样本,并与WCI的其他核心和科学计划密切合作,这是研究生产力和团体科学补助金的支持所证明的。与NCI的合同为癌症基因组图集项目收集和加工胶质母细胞瘤标本也强调了该核心的成功。 HTP和研究病理学实验室共同为WCI研究人员提供了集中,有效和高质量的服务,以加速科学发现。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DANIEL J BRAT其他文献
DANIEL J BRAT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DANIEL J BRAT', 18)}}的其他基金
Modeling the Glioblastoma Microenvironment to Uncover Progression Mechanisms and Therapeutic Targets
模拟胶质母细胞瘤微环境以揭示进展机制和治疗靶点
- 批准号:
10394722 - 财政年份:2020
- 资助金额:
$ 17.02万 - 项目类别:
Modeling the Glioblastoma Microenvironment to Uncover Progression Mechanisms and Therapeutic Targets
模拟胶质母细胞瘤微环境以揭示进展机制和治疗靶点
- 批准号:
10611990 - 财政年份:2020
- 资助金额:
$ 17.02万 - 项目类别:
Identification and targeting of mechanisms specific to glioma stem cells in glioblastoma
胶质母细胞瘤中胶质瘤干细胞特异性机制的鉴定和靶向
- 批准号:
9756347 - 财政年份:2018
- 资助金额:
$ 17.02万 - 项目类别:
Identification and targeting of mechanisms specific to glioma stem cells in glioblastoma
胶质母细胞瘤中胶质瘤干细胞特异性机制的鉴定和靶向
- 批准号:
10434100 - 财政年份:2018
- 资助金额:
$ 17.02万 - 项目类别:
Identification and targeting of mechanisms specific to glioma stem cells in glioblastoma
胶质母细胞瘤中胶质瘤干细胞特异性机制的鉴定和靶向
- 批准号:
10212336 - 财政年份:2018
- 资助金额:
$ 17.02万 - 项目类别:
Identification and targeting of mechanisms specific to glioma stem cells in glioblastoma
胶质母细胞瘤中胶质瘤干细胞特异性机制的鉴定和靶向
- 批准号:
9978761 - 财政年份:2018
- 资助金额:
$ 17.02万 - 项目类别:
Molecular Target Variation Across Environments and at Margins of Glioblastoma
不同环境和胶质母细胞瘤边缘的分子靶标变化
- 批准号:
8675210 - 财政年份:2013
- 资助金额:
$ 17.02万 - 项目类别:
Molecular Target Variation Across Environments and at Margins of Glioblastoma
不同环境和胶质母细胞瘤边缘的分子靶标变化
- 批准号:
9634560 - 财政年份:2013
- 资助金额:
$ 17.02万 - 项目类别:
Molecular Target Variation Across Environments and at Margins of Glioblastoma
不同环境和胶质母细胞瘤边缘的分子靶标变化
- 批准号:
9063107 - 财政年份:2013
- 资助金额:
$ 17.02万 - 项目类别:
Molecular Target Variation Across Environments and at Margins of Glioblastoma
不同环境和胶质母细胞瘤边缘的分子靶标变化
- 批准号:
8502036 - 财政年份:2013
- 资助金额:
$ 17.02万 - 项目类别:
相似国自然基金
人参皂苷Rg5分子尺度调控脂质代谢改善非酒精性脂肪性肝炎机制
- 批准号:22378329
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
氨基酸转运体调控非酒精性脂肪肝的模型建立及机制研究
- 批准号:32371222
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
肝细胞因子ORM2通过抑制Kupffer细胞激活改善非酒精性脂肪性肝炎的作用及机制研究
- 批准号:82300966
- 批准年份:2023
- 资助金额:20 万元
- 项目类别:青年科学基金项目
GW441756基于重塑Thrap3转录调控网络改善非酒精性脂肪肝的新机制
- 批准号:82304586
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
从AMPK调控线粒体裂变和融合研究金钗石斛总生物碱抗非酒精性脂肪肝病的分子机制
- 批准号:82360808
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
相似海外基金
Minimally Invasive High Intensity Therapeutic Ultrasound for the Treatment of Obstructive Hypertrophic Cardiomyopathy
微创高强度超声治疗梗阻性肥厚型心肌病
- 批准号:
10603460 - 财政年份:2023
- 资助金额:
$ 17.02万 - 项目类别:
Impact of Prenatal alcohol on Alzheimer's disease related pathology and cognitive impairment
产前酒精对阿尔茨海默病相关病理和认知障碍的影响
- 批准号:
10570173 - 财政年份:2022
- 资助金额:
$ 17.02万 - 项目类别:
Oral HPV Research Among Latin Americans Living with HIV (ORAL - H² Study)
拉丁美洲艾滋病毒感染者的口腔 HPV 研究(ORAL - H² 研究)
- 批准号:
10703511 - 财政年份:2022
- 资助金额:
$ 17.02万 - 项目类别:
Acute Neural and Immune Effects of Alcohol in People Living with HIV Infection
酒精对艾滋病毒感染者的急性神经和免疫影响
- 批准号:
10666599 - 财政年份:2019
- 资助金额:
$ 17.02万 - 项目类别: